Skip to content

Contact +44 (0) 20 7060 7474 email us

Drug Delivery

Pulmonary Drug Delivery Technologies

A Global Market Perspective

Publication Date November 2009
Publisher BizAcumen
Product Type Report
Pages 165
ISBN Number not applicable
Product Code BIZ00097

Price

£1,980.00
approximately: $2,998 | €2,210

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

Until recent years, respiratory conditions such as asthma, chronic obstructive pulmonary, and emphysema disease represented the sole therapeutic areas of the pulmonary sector. However, recent technological advancements have spanned the application of pulmonary devices to the treatment of non-respiratory conditions such diabetes, migraine. The attractiveness of pulmonary delivery of drugs for the treatment of respiratory diseases stems from the fact that topical drug deposition to infected lung gives a fast therapeutic effect and reduces side effects associated with key drugs.

Advancements in formulating technology are expected to push sales of dry powder inhalers replacing metered-dose inhalers to a larger extent. Dry powder inhalation (DPI), an enabling concept in the noninvasive drug delivery, is progressively emerging as important contender among pulmonary drug delivery methods. This importance is being fueled by latest developments including sophisticated device architectures, growing research activity in powder formulations, and innovations in particle engineering.

These and other market data and trends are presented in "Pulmonary Drug Delivery Technologies: A Global Market Perspective" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Contents

  • 1.Methodology
    • Study Reliability and Reporting Limitations
    • Disclaimers
    • Quantitative Techniques & Reporting Level
  • 2.Market Dynamics
    • Market Overview
    • Pulmonary Devices: Gaining Pace
    • Market Highlights
    • Primary Position of The US
    • Pulmonary Drug Delivery: An Attractive Non-Invasive Option
    • Chief Pulmonary Delivery Technologies
    • Most Effective Route for Respiratory Syndromes
    • Leading Inhalation Prescription Drugs across All Segments
    • The Attractiveness of Inhalers
    • Choice of Drug Delivery System
    • Inhalation Therapy: A Retrospection
    • Pulmonary Drug Delivery - Market Snapshots
  • 3.Trends and Issues
    • Market Snippets
    • Focus of New Age Pulmonary Devices
    • Dry Powder Inhalation: A Promising Technology
    • Research Activities in Inhaled Drug Delivery
    • Lung Versus Oropharyngeal Deposition: A Major Challenge
    • Competitive Environment
    • A Backdrop
    • Market Leaders
    • Industry Efforts
    • Inefficient Use of Pulmonary Drug Delivery Systems
    • Mdis
    • Spacers
    • Dry Powder Inhalers
    • Issues Facing Various Inhalation Devices
    • Jet Nebulizers
    • Mdis
    • Dpis
  • 4.Growth Drivers
    • Growth Drivers in Pulmonary Drug Delivery
    • Use of Nanotechnology in Drug Delivery Products
    • Other Growth Areas
    • Innovative Pulmonary Devices Shape Progress
    • Pulmonary Insulin
    • Alternative Drug Delivery Systems: A Review
    • Market Size
    • Inhaled Small Molecule Therapeutics
  • 5.Product Facts
    • Metered Dose Inhalers (Mdis)
    • Dry Powder Inhalers (Dpis)
    • Nebulizers
  • 6.Regulatory Environment
    • The Montreal Protocol
    • Fda Bans The Use of Cfc's in Metered Dose Inhalers
  • 7.Corporate Developments
    • Sepracor Signs Agreement with Nycomed
    • Kamada Enter into Strategic Pacts with Pari Pharma
    • Glaxosmithkline Ties-up with Amira Pharmaceuticals
    • Consort Medical Releases Meter Dose Inhalers
    • Trinity Chiesi Pharmaceuticals Introduces Fostair
    • Battellepharma Takes over Ventaira Pharmaceuticals
    • Eurand Takes over Sourcecf
    • Aradigm Signs Agreement with Lung Rx Fordeveloping Aerx Essence(R)- Technology
    • Vectura Inks Agreement with A European Company
    • Zyflo CrObtains Fda Clearance
    • Skyepharma Revises Agreement with Abott
    • Alnylam Presents Scientific Progress of Aln-Rsv01
    • Bayer Healthcare and Nektar Therapeutics to Develop Nktr-061
    • Astrazeneca Launches Symbicort
    • Dey, L.P Unveils Perforomist/li>
    • next Safety Rolls out Hi-Performance Drug Delivery Technology
  • 8.Major Players
  • 3m Drug Delivery Systems Division (USA)
    • Akela Pharma Inc (Canada)
    • Alkermes, Inc. (USA)
    • Aradigm Corporation (USA)
    • Astrazeneca Plc (UK)
    • Baxter Healthcare Corporation (USA)
    • Chiesi Farmaceutici Spa (Italy)
    • Consort Medical Plc (UK)
    • Dey L.P. (USA)
    • Glaxosmithkline Plc (UK)
    • Graceway Pharmaceuticals, Llc (USA)
    • Nektar Therapeutics (USA)
    • Oriel Therapeutics, Inc. (USA)
    • Sepracor, Inc. (USA)
    • Skyepharma Plc (UK)
    • Vectura Group Plc (UK)
  • 9.Global Market Analytics
  • 10. The United States
    • Forecast for The near Future
    • Nebulizers: Engraving High Market Interests
    • New Age Pulmonary Drug Delivery Technologies
    • Ranking of Inhaled Prescription Drugs in The US
    • Role of Fda
    • Metered Dose Inhalers
    • Non-Cfc Metered Dose Inhalers
    • Dry Powder Inhalers
    • Popular Dpis in The US
    • Trends in Dpi Devices
    • Drug Delivery Market in The US
    • Competitive Landscape
  • 11.Canada
  • 12.Japan
    • Market Overview
    • Market Highlights
  • 13.Europe
    • A.France
    • B.Germany
    • C.The United Kingdom
    • D.Italy
    • E.Spain
    • F.Russia
    • G.Rest of Europe
  • 14.Asia-Pacific
    • China
    • Market Scenario
    • India
    • Market Scenario
    • Dry Powder Inhalers for Children
    • Device Prices
    • Australia
    • Asthma: The Most Common Chronic Suffering among Australians
    • Australia Finding Preventives for Asthma Cure
    • Use of Cfcs in Australia
  • 15.Latin America
    • Brazil
  • 16.Rest of World
    • Table 1: Percentage Breakdown of Major Brands in The Global Market for Inhaled Drug Delivery Systems -
    • Table 2: Percentage Breakdown of World Market for Pulmonary Drug Delivery Technologies by Drug Category -
    • Table 3: Global Pulmonary Drug Delivery Technologies Market by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 4: Percentage Breakdown of Global Pulmonary Drug Delivery Technologies Market by Region for The Years 2008 &
    • Table 5: Global Metered Dose Inhalers (Mdis) Market by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 6: Percentage Breakdown of Global Metered Dose Inhalers (Mdis) Market by Region for The Years 2008 &
    • Table 7: Global Dry Powder Inhalers (Dpis) Market by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 8: Percentage Breakdown of Global Dry Powder Inhalers (Dpis) Market by Region for The Years 2008 &
    • Table 9: Global Nebulizers Market by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 10: Percentage Breakdown of Global Nebulizers Market by Region for The Years 2008 &
    • Table 11: Percentage Breakdown of US Market for Pulmonary Drug Delivery Technologies by Application Area - 2010p
    • Table 12: Percentage Breakdown of The Non-Cfc Metered Dose Inhalers Market by Application Areas in The US -
    • Table 13: Percentage Breakdown of Non-Cfc Metered Dose Inhalers Primary Manufacturers in The US -
    • Table 14: Percentage Breakdown of Leading Dry Powder Inhalers Manufacturers in The US -
    • Table 15: Percentage Breakdown of Dry Powder Inhalers by Application Areas in The US -
    • Table 16: Pulmonary Drug Delivery Technologies Market by Product Segment in The US: 2007-2015 (Sales in US$ Million)
    • Table 17: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in The US for The Years 2008 &
    • Table 18: Pulmonary Drug Delivery Technologies Market by Product Segment in Canada: 2007-2015 (Sales in US$ Million)
    • Table 19: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Canada for The Years 2008 &
    • Table 20: Percentage Breakdown of Leading Pulmonary Drug Delivery Systems Brands in Japan -
    • Table 21: Pulmonary Drug Delivery Technologies Market by Product Segment in Japan: 2007-2015 (Sales in US$ Million)
    • Table 22: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Japan for The Years 2008 &
    • Table 23: Pulmonary Drug Delivery Technologies Market by Region in Europe: 2007-2015 (Sales in US$ Million)
    • Table 24: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Region in Europe for The Years 2008 &
    • Table 25: Pulmonary Drug Delivery Technologies Market by Product Segment in Europe: 2007-2015 (Sales in US$ Million)
    • Table 26: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Europe for The Years 2008 &
    • Table 27: Pulmonary Drug Delivery Technologies Market by Product Segment in France: 2007-2015 (Sales in US$ Million)
    • Table 28: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in France for The Years 2008 &
    • Table 29: Pulmonary Drug Delivery Technologies Market by Product Segment in Germany: 2007-2015 (Sales in US$ Million)
    • Table 30: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Germany for The Years 2008 &
    • Table 31: Percentage Breakdown of by Major Brands in The UK Market for Inhaled Drug Delivery Systems -
    • Table 32: Pulmonary Drug Delivery Technologies Market by Product Segment in The UK: 2007-2015 (Sales in US$ Million)
    • Table 33: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in The UK for The Years 2008 &
    • Table 34: Percentage Breakdown of Major Pulmonary Drug Delivery Systems Brands in Italy -
    • Table 35: Pulmonary Drug Delivery Technologies Market by Product Segment in Italy: 2007-2015 (Sales in US$ Million)
    • Table 36: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Italy for The Years 2008 &
    • Table 37: Percentage Breakdown of Leading Pulmonary Drug Delivery Systems Brands in Spain -
    • Table 38: Pulmonary Drug Delivery Technologies Market by Product Segment in Spain: 2007-2015 (Sales in US$ Million)
    • Table 39: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Spain for The Years 2008 &
    • Table 40: Pulmonary Drug Delivery Technologies Market by Product Segment in Russia: 2007-2015 (Sales in US$ Million)
    • Table 41: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Russia for The Years 2008 &
    • Table 42: Pulmonary Drug Delivery Technologies Market by Product Segment in Rest of Europe: 2007-2015 (Sales in US$ Million)
    • Table 43: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Rest of Europe for The Years 2008 &
    • Table 44: Pulmonary Drug Delivery Technologies Market by Product Segment in Asia-Pacific: 2007-2015 (Sales in US$ Million)
    • Table 45: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Asia-Pacific for The Years 2008 &
    • Table 46: Pulmonary Drug Delivery Technologies Market by Product Segment in Latin America: 2007-2015 (Sales in US$ Million)
    • Table 47: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Latin America for The Years 2008 &
    • Table 48: Pulmonary Drug Delivery Technologies Market by Product Segment in Rest of World: 2007-2015 (Sales in US$ Million)
    • Table 49: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Rest of World for The Years 2008 &
  • Companies Profiled